Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Malignant Melanoma

  Free Subscription


29.04.2019

3 Am J Dermatopathol
2 Ann Surg Oncol
1 Anticancer Res
2 Br J Dermatol
1 Cancer Res
4 J Am Acad Dermatol
1 J Cell Physiol
6 Melanoma Res
1 Ophthalmol Retina
1 Ophthalmology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Dermatopathol

  1. CHEN ZH, Wang LH
    FARP1 Facilitates Cell Proliferation Through Modulating MAPK Signaling Pathway in Cutaneous Melanoma.
    Am J Dermatopathol. 2019 Apr 16. doi: 10.1097/DAD.0000000000001426.
    PubMed     Text format     Abstract available

  2. FERNANDES M, Barcelos D, Comodo AN, Guimaraes DP, et al
    Acral Lentiginous Melanomas Harbour Intratumor Heterogeneity in BRAF Exon 15, With Mutations Distinct From V600E/V600K.
    Am J Dermatopathol. 2019 Apr 16. doi: 10.1097/DAD.0000000000001418.
    PubMed     Text format     Abstract available

  3. SAGGINI A, Cota C, Lora V, Kutzner H, et al
    Uncommon Histopathological Variants of Malignant Melanoma. Part 2.
    Am J Dermatopathol. 2019;41:321-342.
    PubMed     Text format     Abstract available


    Ann Surg Oncol

  4. BANTING S, Milne D, Thorpe T, Na L, et al
    Negative Sentinel Lymph Node Biopsy in Patients with Melanoma: The Patient's Perspective.
    Ann Surg Oncol. 2019 Apr 22. pii: 10.1245/s10434-019-07375.
    PubMed     Text format     Abstract available

  5. THOMAS DC, Han G, Leong SP, Kashani-Sabet M, et al
    Recurrence of Melanoma After a Negative Sentinel Node Biopsy: Predictors and Impact of Recurrence Site on Survival.
    Ann Surg Oncol. 2019 Apr 22. pii: 10.1245/s10434-019-07369.
    PubMed     Text format     Abstract available


    Anticancer Res

  6. KLEINPOPPEN M, Moebius C, Grupp K, Kluwe L, et al
    Separating Response of Tumor and non-Tumor Cells to Drug In Vitro by Quantifying a Mutation.
    Anticancer Res. 2019;39:1777-1783.
    PubMed     Text format     Abstract available


    Br J Dermatol

  7. VENTURA A, Pitocco R, Di Stefani A, Cota C, et al
    Image Gallery: Peculiar subungual localization of a second primary melanoma during BRAF inhibitors treatment for metastatic melanoma: case report.
    Br J Dermatol. 2019;180:e142.
    PubMed     Text format    

  8. ELEN-LIRA F, Podlipnik S, Potrony M, Tell-Marti G, et al
    Inherited MC1R variants in melanoma patients are associated with better survival in females.
    Br J Dermatol. 2019 Apr 23. doi: 10.1111/bjd.18024.
    PubMed     Text format     Abstract available


    Cancer Res

  9. SHIDAL C, Singh NP, Nagarkatti P, Nagarkatti M, et al
    MicroRNA-92 expression in CD133+ melanoma stem cells regulates immunosuppression in the tumor microenvironment via integrin-dependent activation of TGF-beta.
    Cancer Res. 2019 Apr 23. pii: 0008-5472.CAN-18-2659.
    PubMed     Text format     Abstract available


    J Am Acad Dermatol

  10. BLATTNER CM, Perry B, Young J, Lear W, et al
    2-to-Z flap for reconstruction of adjacent skin defects.
    J Am Acad Dermatol. 2019;80:e77-e78.
    PubMed     Text format    

  11. CHERAGHLOU S, Agogo GO, Girardi M
    System-Level Variations in Treatment Delay for Non-Metastatic Melanoma.
    J Am Acad Dermatol. 2019 Apr 19. pii: S0190-9622(19)30630.
    PubMed     Text format    

  12. HOWARD MD, Wee E, Wolfe R, McLean CA, et al
    Anatomical location of primary melanoma: survival differences and sun exposure.
    J Am Acad Dermatol. 2019 Apr 19. pii: S0190-9622(19)30626.
    PubMed     Text format     Abstract available

  13. KUNISHIGE JH, Doan L, Brodland DG, Zitelli JA, et al
    Comparison of surgical margins for lentigo maligna versus melanoma in situ.
    J Am Acad Dermatol. 2019 Apr 20. pii: S0190-9622(19)30160.
    PubMed     Text format     Abstract available


    J Cell Physiol

  14. SAHRANAVARDFARD P, Firouzi J, Azimi M, Khosravani P, et al
    MicroRNA-203 reinforces stemness properties in melanoma and augments tumorigenesis in vivo.
    J Cell Physiol. 2019 Apr 23. doi: 10.1002/jcp.28619.
    PubMed     Text format     Abstract available


    Melanoma Res

  15. FERNANDEZ-SARTORIO C, Alos L, Garcia-Herrera A, Ferrando J, et al
    Multiple primary melanoma with the Meyerson phenomenon in a young patient.
    Melanoma Res. 2019;29:325-327.
    PubMed     Text format     Abstract available

  16. STRBENAC D, Wang K, Wang X, Dong J, et al
    Melanoma Explorer: a web application to allow easy reanalysis of publicly available and clinically annotated melanoma omics data sets.
    Melanoma Res. 2019;29:342-344.
    PubMed     Text format     Abstract available

  17. PLAQUEVENT M, Greliak A, Pinard C, Duval-Modeste AB, et al
    Simultaneous long-lasting regression of multiple nevi and melanoma metastases after ipilimumab therapy.
    Melanoma Res. 2019;29:311-312.
    PubMed     Text format     Abstract available

  18. WILSON MA, Zhong J, Rosenbaum BE, Utter K, et al
    Impact of initial stage on metastatic melanoma survival.
    Melanoma Res. 2019;29:281-288.
    PubMed     Text format     Abstract available

  19. MANRIQUE-SILVA E, Reyes-Garcia D, Traves V, Rachakonda S, et al
    TERT promoter mutation subtypes in 20 in-situ melanomas.
    Melanoma Res. 2019;29:347-348.
    PubMed     Text format    

  20. FERNANDEZ-DIAZ AB, Garcia-Medina A, Ferrer-Guillen B, Berrocal A, et al
    Eye immune privilege? Nivolumab plus ipilimumab: successful treatment in a patient with cutaneous melanoma and ocular metastases.
    Melanoma Res. 2019;29:345-347.
    PubMed     Text format    


    Ophthalmol Retina

  21. SHAO YF, Echegaray JJ, Singh N, Singh AD, et al
    Variability of Bad Prognosis in Uveal Melanoma.
    Ophthalmol Retina. 2019;3:186-193.
    PubMed     Text format     Abstract available


    Ophthalmology

  22. VICHITVEJPAISAL P, Dalvin LA, Mazloumi M, Ewens KG, et al
    Genetic Analysis of Uveal Melanoma in 658 Patients using The Cancer Genome Atlas (TCGA) Classification of Uveal Melanoma as A, B, C & D.
    Ophthalmology. 2019 Apr 23. pii: S0161-6420(19)30611.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: